Biogen CEO: Alzheimer's drug shows positive results

7:32 AM ET Thu, 26 July 2018

Michel Vounatsos, Biogen CEO, talks the company's commitment to find drugs that slow the progression of Alzheimer's disease, and shares his thoughts on drug pricing.